Status:
COMPLETED
Efficacy and Safety of NVP-1203 and NVP-1203-R in Patients With Acute Low Back Pain
Lead Sponsor:
NVP Healthcare
Conditions:
Acute Low Back Pain
Eligibility:
All Genders
19+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the efficacy and safety NVP-1203 in patients with acute low back pain.
Detailed Description
This study is a randomized, double-blind, active-controlled, parallel, phase 3 study to evaluate efficacy and safety of NVP-1203 in patients with acute low back pain.
Eligibility Criteria
Inclusion
- Subjects who have ability to comprehend the contents of study and before participating in trial and have willingness to sign of informed consent in writing
- Subjects who have symptom of acute low back pain
Exclusion
- Subjects who cannot prohibit anti-inflammatory drug or muscle relaxants during clinical trial
- Inadequate subject for the clinical trial by the investigator's decision
Key Trial Info
Start Date :
January 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2021
Estimated Enrollment :
421 Patients enrolled
Trial Details
Trial ID
NCT04082975
Start Date
January 15 2020
End Date
May 31 2021
Last Update
June 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Navipharm
Suwon, Gyeonggi-do, South Korea, 16209